Customized data and analyses to address pharmaceutical and biotech pipeline or portfolio challenges
“ Evaluate Custom Solutions paid careful attention to our report needs, and the after-care service was excellent, so our level of satisfaction was extremely high. It was one of the best services that I have experienced so far. ”
“ I really could not do my job without Evaluate data. You guys make me look good all the time. ”
Over the last year, 13 of the world’s largest pharmaceutical and biotech companies have engaged Evaluate Custom Solutions in addressing their biggest global challenges. These clients have engaged us to provide insight to help inform a range of their key objectives including: Market Analysis & Competitor Intelligence, Corporate Strategy & Franchise Planning, Market Expansion & Forecasting, Mergers & Acquisition, New Product Development, Market Access and Pricing & Commercialization.
Below are some examples of the work we have undertaken for the likes of Abbvie, Amgen, AstraZeneca, Bayer, Daiichi Sankyo, Gilead, GSK, Johnson & Johnson/Janssen, Merck KGaA, Novartis, Pfizer, Roche/Chugai and Sanofi.
An external industry perspective to complement your views on the market, competition, and your company's strategic direction.
Find out how a major global pharma gained an external perspective on market trends to support a key Executive Team strategy session.
Objective, data-driven insights to validate if you are making the right choices for your product portfolio.
Find out how a Japanese pharma company benchmarked the R&D productivity of peer companies for insight into potential patterns and drivers.
Expedite your search and screen efforts and access robust, data-driven analysis to support opportunity assessment.
Find out how a mid-sized pharma BD&L team outsourced their search and screen efforts for a shortlist of assets with potential for licensing.
Customized epidemiology research, forecast modelling, and pricing analysis to inform your product strategy and tactical planning.
Find out how a pharma commercial and finance group established a standard forecasting methodology across an entire business.
Feed industry-leading Evaluate commercial intelligence directly into your internal tools, systems and workflows via data feeds and APIs.
Find out how a major US pharma created a live M&A target screening tool by integrating Evaluate data into a data visualization dashboard.
Our services are designed for teams defining product and portfolio strategy and setting direction for key brands and franchises. We provide insight into Market Analysis & Competitor Intelligence, Corporate Strategy & Franchise Planning, Market Expansion & Forecasting, Mergers & Acquisition, New Product Development, Market Access and Pricing & Commercialization.
Leveraging a foundation of extensive Evaluate data augmented with further secondary research, modelling, and analysis, our solutions are data-driven and insight-focused. We also conduct targeted primary research with Key Opinion Leaders, Healthcare Professionals and Payers to validate our assumptions and test our hypotheses.
Below we have provided an overview of our services and how they apply to the life stages of companies / products. Please click on the “+” to find out more. If there is something that is not listed here please contact us so we can work with you to get you the insights you need.
High impact, forward-looking insight into market trends and the drivers fuelling the growth of the industry, providing outside-in perspectives on market evolution and your company’s positioning in the landscape.
Rigorous research and analysis to construct fully customised and focused fit-for-purpose epidemiology models, designed to underpin market sizing, opportunity assessment, product targeting, and product value measurement.
Robust comparative assessments leveraging unique Evaluate metrics and incorporating scientific, clinical, and commercial drivers, providing insights to guide informed portfolio strategy and prioritisation decision making.
Deep analysis of product differentiators and value in the context of an ever evolving and dynamic market, providing objective perspectives to influence product targeting and strategy in support of development planning, fund-raising, and deal-making.